Schizophrenia News and Research

Latest Schizophrenia News and Research

Salty diet may trigger autoimmune disease

Salty diet may trigger autoimmune disease

Treating substance abuse alone helps patients with co-occurring psychosis

Treating substance abuse alone helps patients with co-occurring psychosis

Vitamin B12 and folate alleviate negative symptoms in patients with schizophrenia

Vitamin B12 and folate alleviate negative symptoms in patients with schizophrenia

Fractional anisotropy examines age-related decline in cerebral white matter in schizophrenia, MDD

Fractional anisotropy examines age-related decline in cerebral white matter in schizophrenia, MDD

Selective activation of the dentate gyrus can reduce anxiety without affecting learning

Selective activation of the dentate gyrus can reduce anxiety without affecting learning

Non-social cognitive deficits outweigh social ones in bipolar disorder

Non-social cognitive deficits outweigh social ones in bipolar disorder

Foreign-born adoptees most at risk for psychiatric disorders

Foreign-born adoptees most at risk for psychiatric disorders

Pain self-management and exercise ‘effective in elderly’

Pain self-management and exercise ‘effective in elderly’

UK’s health performance declining compared with 14 EU countries over past 20 years

UK’s health performance declining compared with 14 EU countries over past 20 years

Quitting cannabis may not alleviate psychosis

Quitting cannabis may not alleviate psychosis

Gene cluster implicated in Behçet's disease

Gene cluster implicated in Behçet's disease

Omalizumab scratches the itch for urticaria patients

Omalizumab scratches the itch for urticaria patients

Forceps delivery ‘does not increase atopy risk’

Forceps delivery ‘does not increase atopy risk’

Schizophrenic people with MIR137 tend to develop illness at younger age

Schizophrenic people with MIR137 tend to develop illness at younger age

KMO gene variant associated with increased production of kynurenic acid

KMO gene variant associated with increased production of kynurenic acid

Positive results from NeuroDerm ND0612 Phase I trial on Parkinson's

Positive results from NeuroDerm ND0612 Phase I trial on Parkinson's

Combination of two environmental factors contributes to schizophrenia

Combination of two environmental factors contributes to schizophrenia

Otsuka receives FDA approval for ABILIFY MAINTENA to treat schizophrenia

Otsuka receives FDA approval for ABILIFY MAINTENA to treat schizophrenia

Autism, ADHD, bipolar disorder, major depressive disorder and schizophrenia share common genetic risk factors

Autism, ADHD, bipolar disorder, major depressive disorder and schizophrenia share common genetic risk factors

Symptom profile changes between first-episode and chronic schizophrenia

Symptom profile changes between first-episode and chronic schizophrenia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.